Fig. 1.

Proportion of (i) newly diagnosed patients by country not initiating therapy within 2 months of diagnosis, (ii) reasons for not initiating maintenance therapy within 2 months of diagnosis, and (iii) cost/access restrictions as a reason for newly diagnosed patients not initiating therapy within 2 months of diagnosis by country. §Other reasons included a need to wait until after acute treatment and logistics, such as scheduling infusions. Data presented in (i) are for all newly diagnosed patients who had not been initiated on therapy within 2 months of diagnosis by country as a proportion of all newly diagnosed patients (N = 472). Data presented in (ii) are reasons given for not initiating therapy within 2 months of diagnosis as a proportion of all patients that were receiving therapy at the time of the survey (N = 151); stable disease (n = 60), patient refusal (n = 49), cost/access restrictions (n = 28), other (n = 14). Data presented in (iii) are for all newly diagnosed patients receiving treatment at the time of the survey that mentioned cost/access restrictions as a reason for not being initiated on therapy within 2 months of diagnosis (N = 28); China (n = 7), South Korea (n = 4), the USA (n = 12), Germany (n = 3), Brazil (n = 1), Italy (n = 1)